{"id":"W4280526151","doi":"10.1093/cid/ciac381","title":"Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States","year":2022,"lang":"en","type":"article","venue":"Clinical Infectious Diseases","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; Centers for Disease Control and Prevention; Regeneron Pharmaceuticals; National Institutes of Health; Pfizer; Incyte; York University; Society of Hospital Medicine; Janssen Pharmaceuticals; University of Washington; Cincinnati Children's Hospital Medical Center; National Heart, Lung, and Blood Institute; Cumberland Pharmaceuticals; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; United Therapeutics Corporation; Medpace; American Thoracic Society; Agency for Healthcare Research and Quality; American Lung Association; U.S. Department of Defense; Sanofi; Gilead Sciences","keywords":"Medicine; Interquartile range; Vaccination; Confidence interval; Odds ratio; Internal medicine; Confounding; Logistic regression; Immunology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001068629,0.0001944095,0.0001997348,0.0002665457,0.0002144113,0.0003528414,0.000178023,0.0003063324,0.001036265],"category_scores_gemma":[0.003188863,0.0001339812,0.000318146,0.0002329361,0.000152437,0.0002616654,0.0002301957,0.0003160742,0.00009501071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003574477,"about_ca_system_score_gemma":0.0002556996,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005407539,"about_ca_topic_score_gemma":0.00522684,"domain_scores_codex":[0.9994807,0.0001809087,0.00004826888,0.0001159608,0.00007682498,0.00009741056],"domain_scores_gemma":[0.9983323,0.0002577965,0.001082637,0.00006246563,0.0001039636,0.0001607239],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0002949802,0.00006707205,0.9967324,0.00001173718,0.00004707865,0.00004376828,0.00004614065,0.00004656173,0.0001998294,0.00002240107,0.0002137707,0.002274374],"study_design_scores_gemma":[0.0000163298,0.0004898898,0.9986307,0.00001717597,0.00003257643,0.0001631318,0.00007626085,0.0002561421,0.0001270623,0.00001884324,0.0001700319,0.000001769987],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9991822,0.0002804248,0.00005238353,0.00005813749,0.000007898156,0.000005263318,0.0001820209,0.000002676222,0.0002290643],"genre_scores_gemma":[0.9996427,0.00007534034,0.00002636601,0.00002921375,0.00000587024,0.000003260732,0.0001702307,4.110616e-7,0.00004658986],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005407539,"threshold_uncertainty_score":0.01075214,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04522016082215431,"score_gpt":0.3874260199764079,"score_spread":0.3422058591542536,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}